Clinical Trial Update: Expressive Writing for Reducing Stress and Diabetic Symptoms in Diabetes Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating expressive writing to reduce stress and diabetic symptoms in people with diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Major Depressive Disorder

Snippet

Sponsor: Syracuse University | Conditions: Diabetes Mellitus, Stress | Phase 2 | Status: COMPLETED